At the HSJ medicines forum this month, the great and the good of NHS drug decision-making units gathered to give their state of the nation addresses.
NICE was represented by chief exec Sam Roberts, and one of the more striking things she said was that up to 40% of their time at the moment was spent on working through 50 different applications of the same three medicines.
Three medicines, 40% of NICE’s time, might sound extremely odd, but this is the new world we find ourselves in with complex biologics.
Check out the rest of the feature here
